{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:40:29Z","timestamp":1784641229513,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejso.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:50:14Z","timestamp":1684464614000},"page":"106937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2896-0164","authenticated-orcid":false,"given":"Masakuni","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Yokoi-Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Haba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02967068","article-title":"The role of axillary lymph node dissection in breast cancer management","volume":"4","author":"Noguchi","year":"1997","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2023.05.012_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Raditherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.breast.2021.08.018","article-title":"Axillary surgery in node-positive breast cancer","volume":"62","author":"Maggi","year":"2022","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ejso.2023.05.012_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12282-022-01409-2","article-title":"Conservative axillary surgery is emerging in the surgical management of breast cancer","volume":"30","author":"Noguchi","year":"2023","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","article-title":"Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation","volume":"14","author":"Thompson","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1245\/s10434-007-9450-4","article-title":"Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection","volume":"14","author":"Nos","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clbc.2015.01.010","article-title":"A\u00a0prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients","volume":"15","author":"Yue","year":"2015","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2023.05.012_bib9","article-title":"Identification and preservation of arm lymphatic system in axillary dissection for breast cancer to reduce arm lymphedema events: a randomized clinical trial","volume":"26","author":"Yuan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13037-019-0217-1","article-title":"Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: a randomized controlled trial","volume":"13","author":"Faisal","year":"2019","journal-title":"Patient Saf Surg"},{"key":"10.1016\/j.ejso.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijsu.2020.01.152","article-title":"Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients -randomized controlled trial","volume":"75","author":"Abdelhamid","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2023.05.012_bib12","first-page":"1","article-title":"Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: a two-arm randomized clinical trial","author":"Gennaro","year":"2022","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-009-0578-8","article-title":"Axillary reverse mapping for breast cancer","volume":"119","author":"Noguchi","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/01.prs.0000246516.64780.61","article-title":"The lymphatic territories of the upper limb: anatomical study and clinical implications","volume":"119","author":"Suami","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1245\/s10434-012-2363-x","article-title":"Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study","volume":"19","author":"Pavlista","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejso.2015.01.029","article-title":"Is axillary reverse mapping feasible in breast cancer patients?","volume":"41","author":"Noguchi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21473","article-title":"Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer","volume":"101","author":"Noguchi","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jso.24859","article-title":"Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes","author":"Foster","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jso.23528","article-title":"Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies","volume":"109","author":"Sakurai","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2022.07.004","article-title":"Axillary reverse mapping near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study)","author":"Conversano","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12282-021-01300-6","article-title":"The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer","volume":"29","author":"Noguchi","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12282-016-0684-5","article-title":"The roles of 18F-FDG-PET\/CT and US-guided FNAC in assessment of axillary nodal metastases in breast cancer patients","volume":"24","author":"Nakano","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jso.21308","article-title":"Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy","volume":"100","author":"Noguchi","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American society of clinical oncology guideline. Recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/SLA.0000000000001778","article-title":"Does axillary reverse mapping prevent lymphedema after lymphadenectomy","volume":"265","author":"Tummel","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-020-08650-z","article-title":"Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy","volume":"27","author":"Montagna","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejso.2014.09.012","article-title":"Axillary reverse mapping (ARM) in clinically node positive breast cancer patients","volume":"41","author":"Beek","year":"2015","journal-title":"EJSO"},{"key":"10.1016\/j.ejso.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3390\/cancers14112614","article-title":"Near-infrared fluorescece axillary reverse mapping (ARM) procedure in invasive breast cancer: relationship between fluorescence signal in ARM lymph nodes and clinical outcomes","volume":"14","author":"Abbaci","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/jamaoncol.2015.3717","article-title":"Temporal trends in postmastectomy radiation therapy and breast reconstruction associated with changes in national comprehensive cancer network guidelines","volume":"2","author":"Frasier","year":"2016","journal-title":"JAMA Onco"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:50:15Z","timestamp":1760061015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323005061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0748798323005061"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.05.012","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106937"}}